1. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis
   Kyung Ha Lee et al, 2017 CrossRef
2. MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression
   Jiangman Duan et al, 2017 CrossRef
3. Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer
   Ben Yue et al, 2016, Molecular Therapy CrossRef
4. Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells
   Samir Attoub et al, 2018, Nutrients CrossRef
5. Emerging role of lipid metabolism alterations in Cancer stem cells
   Mei Yi et al, 2018, J Exp Clin Cancer Res CrossRef
6. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
   Yisheng Liu et al, 2014, DNA Cell Biol. CrossRef
7. Small-Molecule Modulation of Lipid-Dependent Cellular Processes against Cancer: Fats on the Gunpoint
   Aswin T. Srivatsav et al, 2018, BioMed Research International CrossRef
8. β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1
   Xiaoqiang Li et al, 2016, Sci Rep CrossRef
9. Natural products for treating colorectal cancer: A mechanistic review
   Xuan-mei Huang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
10. A Chinese herbal Formula, Chang-Wei-Qin, Synergistically Enhances Antitumor Effect of Oxaliplatin
    Yong Zhang et al, 2015, Pathol. Oncol. Res. CrossRef
11. The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth
    Arvin M. Gouw et al, 2019, Cell Metabolism CrossRef
12. Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
    Dirk O Bauerschlag et al, 2015, J Transl Med CrossRef
13. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway
    Ligong Chang et al, 2016, J Cancer Res Clin Oncol CrossRef
14. Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma
    Christina A von Roemeling et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
15. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway
    Yan Liu et al, 2016, Apoptosis CrossRef
16. Colorectal cancer stem cells: a review of targeted drug delivery by gold nanoparticles
    Manali Haniti Mohd-Zahid et al, 2020, RSC Adv. CrossRef
17. p53 and metabolism: from mechanism to therapeutics
    Fernando M. Simabuco et al, 2018, Oncotarget CrossRef
18. Targeting cytosolic phospholipase A2 α in colorectal cancer cells inhibits constitutively activated protein kinase B (AKT) and cell proliferation
    Zhong Zheng et al, 2014, Oncotarget CrossRef
19. Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A2α via AKT in prostate cancer cells
    Soma Vignarajan et al, 2014, Oncotarget CrossRef
20. Fatty Acid Synthase: An Emerging Target in Cancer.
    Chee Wai Fhu et al, 2020, Molecules CrossRef
21. Arachidonic acid induces ER stress and apoptosis in HT-29 human colon cancer cells
    Sijeong Bae et al, 2020, Animal Cells and Systems CrossRef
22. Metabolic Targeting of Cancer Stem Cells
    Anna Mukha et al, 2020, Front. Oncol. CrossRef
23. An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis
    Dina S. Stepanova et al, 2017, Cancer Res CrossRef
24. Metabolic Strategies for Inhibiting Cancer Development
    Philippe Icard et al, 2021 CrossRef
25. Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
    Chelsea Schiliro et al, 2021, Cells CrossRef
26. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
    Miljana Nenkov et al, 2021, Int J Mol Sci CrossRef
27. null
    Tomas Koltai et al, 2021 CrossRef
28. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment.
    Lumei Kang et al, 2021, J Neurol CrossRef
29. Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
    Yang Yang et al, 2021, J Exp Clin Cancer Res CrossRef
30. Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy
    Jasmeet Kaur et al, 2021, Front. Oncol. CrossRef
31. How cancer cells remodel lipid metabolism: strategies targeting transcription factors
    Do-Won Jeong et al, 2021, Lipids Health Dis CrossRef
32. Targeting Energy Metabolism in Cancer Treatment
    Joanna Kubik et al, 2022, IJMS CrossRef
33. The Potential Role of Changes in the Glucose and Lipid Metabolic Pathways in Gastrointestinal Cancer Progression: Strategy in Cancer Therapy
    Gordon A. Ferns et al, 2021, Gastrointest Tumors CrossRef
34. Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells
    Shiliu Tian et al, 2022, JPM CrossRef
35. Comparative Study of Autophagy in Oxaliplatin-Sensitive and Resistant SNU-C5 Colon Cancer Cells
    Sun-Jin Boo et al, 2022, Biomol Ther (Seoul) CrossRef
36. Colon cancer and colorectal cancer: Prevention and treatment by potential natural products
    Md Rezaul Islam et al, 2022, Chemico-Biological Interactions CrossRef
37. Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers
    Deborah Y. Moss et al, 2022, Sci. Signal. CrossRef
38. Lipid metabolism reprogramming in colorectal cancer
    Dan Chen et al, 2022, J of Cellular Biochemistry CrossRef
39. Comprehensive Analysis of FASN in Tumor Immune Infiltration and Prognostic Value for Immunotherapy and Promoter DNA Methylation
    Mingyang Zhang et al, 2022, IJMS CrossRef
40. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach
    Nima Zafari et al, 2022, CPD CrossRef
41. Overview of Cancer Metabolism and Signaling Transduction
    Hee-Suk Chae et al, 2022, IJMS CrossRef
42. Single‐Atom Nanozyme with Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis
    Yang Liu et al, 2023, Advanced Materials CrossRef
43. Metabolomics in oncology
    Gurparsad Singh Suri et al, 2023, Cancer Reports CrossRef
44. Metabolic reprogramming in cancer: Mechanisms and therapeutics
    Shiqi Nong et al, 2023, MedComm CrossRef
45. Targeting autophagy and lipid metabolism in cancer stem cells
    Bandana Chakravarti et al, 2023, Biochemical Pharmacology CrossRef
46. Protein Folding Stability Profiling of Colorectal Cancer Chemoresistance Identifies Functionally Relevant Biomarkers
    Baiyi Quan et al, 2023, J. Proteome Res. CrossRef
47. Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness
    Zhiqing Huang et al, 2023, Sci Rep CrossRef
48. Role of EGFR and FASN in breast cancer progression
    Suchi Chaturvedi et al, 2023, J. Cell Commun. Signal. CrossRef
49. Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors
    Sultan Neja et al, 2024, Nutrients CrossRef
50. Oleate Epoxides Derived from Palm Oil as New Anticancer Agents: Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies Against FASN Protein
    Baiq R. Fatmayanti et al, 2024, ChemistrySelect CrossRef
51. Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy
    Domiziana Masci et al, 2024, Molecules CrossRef
52. null
    Natalia Kurhaluk et al, 2024 CrossRef